Dr. Talia Golan

Dr. Talia Golan, an esteemed clinical oncologist, is making significant contributions to the field of pancreatic malignancies. As the Head of the Department of Pancreatic Malignancies at SHEBA Medical Center in Ramat Gan, Israel, Dr. Golan is at the forefront of innovative research and patient treatment options. Her expertise and dedication have earned her recognition as one of the 50 most influential women in Israel by Forbes in 2019. Dr. Golan's impressive credentials include studying human medicine at Tel Aviv University and obtaining a license for medical practice. She further specialized in clinical oncology, focusing her career on the early detection and treatment of pancreatic cancer. With a remarkable 290 scientific publications to her name, Dr. Golan's research encompasses various aspects of cancer treatment and can potentially revolutionize the field. The impact of Dr. Golan's work is evident in her role as the Medical Director of the early phase clinical trials program at SHEBA Medical Center. This program allows patients to access cutting-edge treatments and participate in groundbreaking research. Dr. Golan's commitment to improving patient outcomes and extensive field experience make her a highly sought-after oncologist.